Martin Madaus

Martin Madaus

Chairman presso QUANTERIX CORPORATION

Patrimonio netto: 7 M $ in data 31/03/2024

64 anni
Health Technology
Commercial Services
Health Services

Profilo

Martin D.
Madaus
is currently serving as the Chairman at Quanterix Corp.
since 2022 and as the Executive Chairman at Emulate, Inc. since 2020.
He is also a Director at Candela Corp., Repligen Corp., Azenta, Inc., Massachusetts High Technology Council, Inc., Unchained Labs, Ultivue, Inc., Candela Medical, Inc., Syntis Bio, Inc., Unchained Labs LLC, and Sherlock Biosciences, Inc. Additionally, Dr. Madaus has held former positions as the Chairman, President & Chief Executive Officer at EMD Millipore Corp.
from 2005 to 2010, Chairman & Chief Executive Officer at Ortho-Clinical Diagnostics, Inc. from 2014 to 2019, President & Chief Executive Officer at Roche Diagnostics Corp.
from 2000 to 2004, Chairman, President & Chief Executive Officer at Millipore SA from 2005 to 2010, and Vice President-Business Development at Roche Molecular Systems, Inc. He has also served as a Director at Pharmaceutical Product Development LLC, Mettler-Toledo International, Inc., Standard BioTools, Inc., Covidien Unlimited Co., New England Healthcare Institute, Massachusetts Technology Collaborative, Predictive Biosciences, Inc., Young Men's Christian Association of Greater Boston, Inc., and Analytical Life Science & Diagnostics Association.
Dr. Madaus holds a doctorate degree from Ludwig-Maximilians-Universität München and The University of Veterinary Medicine Hanover.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
02/01/2024 276 023 ( 0.73% ) 7 M $ 31/03/2024
18/05/2023 2 308 ( 0.00% ) 424 487 $ 31/03/2024
20/10/2023 104 111 ( 0.04% ) 282 141 $ 31/03/2024
12/02/2024 2 465 ( 0.00% ) 148 590 $ 31/03/2024

Posizioni attive di Martin Madaus

SocietàPosizioneInizio
QUANTERIX CORPORATION Chairman 08/08/2022
CANDELA MEDICAL, INC. Director/Board Member 01/05/2018
REPLIGEN CORPORATION Director/Board Member 06/02/2023
AZENTA, INC. Director/Board Member 30/01/2024
Director/Board Member -
Director/Board Member -
Director/Board Member 01/07/2021
Director/Board Member 01/07/2021
Chief Operating Officer 09/09/2020
░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Tutte le posizioni attive di Martin Madaus

Precedenti posizioni note di Martin Madaus

SocietàPosizioneFine
░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Martin Madaus

Formazione di Martin Madaus

Ludwig-Maximilians-Universität München Doctorate Degree
The University of Veterinary Medicine Hanover Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Martin Madaus

Relazioni

99

Relazioni di 1° grado

30

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa5
REPLIGEN CORPORATION

Health Technology

AZENTA, INC.

Health Services

METTLER-TOLEDO INTERNATIONAL, INC.

Health Technology

STANDARD BIOTOOLS INC.

Health Technology

QUANTERIX CORPORATION

Health Technology

Aziende private23

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Technology Services

Health Technology

Commercial Services

Health Services

Commercial Services

Health Services

Commercial Services

Electronic Technology

Boehringer Mannheim Corp. (California)

Analytical Life Science & Diagnostics Association

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Vedi le connessioni aziendali